Impact of Medication Education on Adherence and Side Effects

Starting soon · Not applicable

Conditions studied: Schizophrenia, Schizoaffective Disorder, Bipolar Disorder With Psychotic Features, Major Depressive Disorder With Psychotic Features

In brief

Severe mental disorders such as schizophrenia, bipolar disorder, and psychotic depression often require long-term or lifelong medication treatment. However, many psychiatric patients have difficulty adhering to their prescribed medication regimens due to factors such as lack of information, fear of side effects, and negative experiences with psychotropic medications. Poor treatment adherence is associated with symptom relapse, prolonged hospitalization, increased rehospitalization rates, reduced quality of life, and higher health care costs. Medication education is a key psychosocial intervention aimed at improving patients' understanding of their illness, treatment process, and potential medication side effects. Providing structured medication education may enhance treatment adherence and help patients recognize and manage side effects more effectively. This intervention study aims to evaluate the effect of a structured medication education program on treatment adherence and medication-related side effects among psychotic inpatients hospitalized in a psychiatric clinic, including patients diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, bipolar disorder with psychotic features, and major depressive disorder with psychotic features. The findings of this study are expected to contribute to the development of effective psychosocial interventions to improve medication adherence and treatment outcomes in psychiatric inpatient settings.

Key facts

Study ID

NCT07374588

Run by

Cumhuriyet University

People needed

64

Starts

2026-01-02

Expected to finish

2026-06-02

Last updated by the study team

2026-01-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged 18-65 years
• Hospitalized in a psychiatric inpatient clinic
• Diagnosed with schizophrenia, schizoaffective disorder, schizophreniform disorder, bipolar disorder with psychotic features, or major depressive disorder with psychotic features
• Receiving psychotropic medication treatment
• Clinically stable and able to participate in educational sessions
• Able to communicate verbally and understand the content of the education
• Provided written informed consent

You may not qualify if…

• Presence of severe cognitive impairment or intellectual disability
• Acute medical or neurological conditions that may interfere with participation
• Severe agitation or acute psychotic symptoms preventing participation
• Hearing or communication impairments that limit participation in educational sessions
• Participation in another psychosocial intervention study during the study period

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.